Kravchenko Dmitrij, Hagar Muhammad Taha, Vecsey-Nagy Milan, Tremamunno Giuseppe, Szilveszter Bálint, Vattay Borbála, Zsarnóczay Emese, Beke Sámuel, Maurovich-Horvat Pál, Emrich Tilman, Varga-Szemes Akos
Department of Radiology and Radiological Science, Medical University of South Carolina, Charleston, USA.
Department of Diagnostic and Interventional Radiology, University Hospital Bonn, Bonn, Germany.
Echocardiography. 2025 Feb;42(2):e70100. doi: 10.1111/echo.70100.
It was only fitting that when computed tomography (CT) was celebrating its 50th birthday since its maiden scan in 1971, it was also entering into a new generation in 2021 with the Food and Drug Administration's approval of the first photon-counting detector (PCD)-CT. As non-invasive cardiac imaging is evolving into an ever more important medical field, the introduction of this new technology promises a slew of improvements over energy-integrating detector (EID)-CTs, most importantly improved spatial resolution in the form of ultrahigh-resolution (UHR) imaging, reduced radiation exposure, and routinely acquired spectral information. Spatial resolution has historically been a key hurdle for cardiac CT, especially for coronary imaging where structures in the realm of 2 mm need to be assessed. Initial reports on the use of PCD-CT in cardiac imaging so far have been promising, but many questions ranging from standardized scan protocols to evidence-based recommendations remain. The aim of this review is to discuss the currently available literature regarding the use of UHR PCD-CT for cardiac imaging and explore if it has led to changes in guidelines or patient workflows.
1971年首次扫描以来,计算机断层扫描(CT)迎来其50周年诞辰之际,恰逢2021年随着美国食品药品监督管理局批准首款光子计数探测器(PCD)-CT进入新一代。随着无创心脏成像发展成为一个日益重要的医学领域,这项新技术的引入有望在诸多方面优于能量积分探测器(EID)-CT,最重要的是在超高分辨率(UHR)成像方面提高空间分辨率、减少辐射暴露,并常规获取光谱信息。历史上,空间分辨率一直是心脏CT的关键障碍,尤其是在冠状动脉成像中,需要评估2毫米范围内的结构。目前关于PCD-CT在心脏成像中应用的初步报告很有前景,但从标准化扫描方案到循证建议等诸多问题依然存在。本综述的目的是讨论目前关于UHR PCD-CT用于心脏成像的可用文献,并探讨其是否导致了指南或患者工作流程的改变。